Queen Square Institute of Neurology

United Kingdom - London

Go to:

Specialists in this centre

Professor of Neurology

London,United Kingdom

Open for participation

The MAGNET lithium trial studies the efficacy of lithium carbonate in ALS patients positive for the homozygous UNC13A mutation.

Closed for participation

The Lighthouse 2 study is a phase 3 clinical trial in which we will investigate the efficacy of the drug Triumeq.

Archived

Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound 'AMX0035'.

If you would like to contact us or register for a trial, leave your details here.